The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Cubus Lux

7 Feb 2006 16:55

AIM07 February 2006 ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH AIM RULE 2 ALL APPLICANTS MUST COMPLETE THE FOLLOWING: COMPANY NAME:Cubus Lux Plc COMPANY ADDRESS:66 Wigmore Street, London COMPANY POSTCODE:W1U 2SB COUNTRY OF INCORPORATION:England COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED INACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J) OF THE AIM RULES:Cubus currently operates three casinos in Croatia and is the second largest casino operator in Croatia. TheCompany is also in the process of building a marina (Olive Island Marina) in Croatia. Olive Island Marina issituated in Sutomiscica on the island of Ugljan which is approximately 4 miles from the city of Zadar. All themarina berths will be equipped with modern facilities and the initial phase with approximately 200 marina berthsis expected to become operational by June 2006. DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to whichit seeks admission and the number and type to be held as treasury shares):Reverse acquisition, placing and current shares in issue totalling; 67,352,001 ordinary shares of 1p each at 10p per share CAPITAL TO BE RAISED ON ADMISSION:Placing of £1,025,000 FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:Directors: Dr Gerhard Heribert Huber, Executive ChairmanMichael Martin Janssen, Non-Executive DirectorLeon Rodolfo Nahon, Non-Executive DirectorHaggai Ravid, Non-Executive DirectorEli Abramovich, Non-Executive Director Proposed Director:Christian Kaiser, Chief Operating Officer PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITALBEFORE AND AFTER ADMISSION:Before Mr Lucian Alter 3,299,588 - 14.93%Gerhard Huber 2,669,513 - 12.1%Michael Janssen 2,052,750 - 9.3%Brada Investments Limited 1,120,000 - 5%Haggai Ravid 894,050 4%CSS Bridge Partners LP (Series D2) 880,000 - 3.98%CSS 770,000 - 3.48%Stefan Roever 1,564,000 - 7% After Gerhard Huber - 14,336,180 - 21.29%Christian Kaiser - 12,266,666 - 18.21%Milan Kotur - 11,666,666 - 17.32%Lucian Alter - 4.90%Michael Janssen - 2,052,750 - 3.05%Bruno Kling - 3,000,000 - 4.45% NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:Cukierman & Co, a company of which Haggi Ravid is a director, is entitled to a fee equivalent to 5 per cent. of the gross proceeds placed by introduced parties of Cukieman pursuant tothe Placing. Cukierman & Co3, Daniel Frish St.Tel-Aviv 64731 ANTICIPATED ACCOUNTING REFERENCE DATE:31 December EXPECTED ADMISSION DATE:6 March 2006 NAME AND ADDRESS OF NOMINATED ADVISER:Corporate Synergy Plc30 Old Broad StreetLondon EC2N 1HT NAME AND ADDRESS OF BROKER:As above DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENTTHAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES: As above DATE OF NOTIFICATION: 7 February 2006 NEW/ UPDATE (see note):NEW This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.